Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2016

View Archived Issues

[11C]AS-2471907: a radioligand for PET imaging of brain 11beta-HSD1

Changes in absolute lymphocyte counts following up to 8 years of tofacitinib treatment

Galapagos offers R&D update

PSMA-ADC shows no activity in patients with progressive glioblastoma

Capricor Therapeutics reports preliminary data from study of CAP-1002 in heart failure

Phase III KEYNOTE-24 study of Keytruda in advanced NSCLC meets primary endpoint

European Commission approves Gazyvaro in follicular lymphoma

Astellas Pharma and Kotobuki Pharmaceutical patent leucyl-cystinyl aminopeptidase antagonists

Eli Lilly discloses EZH2 inhibitors

C&C Research Laboratories describes STAT3 inhibitors

Sagent Pharmaceuticals enters deal to acquire ANDAs from Teva

Shionogi develops P2X3 and/or P2X2/3 receptor antagonists

Ono Pharmaceutical presents S1P5 receptor agonists

RPC-8844 demonstrates promising efficacy in mouse models of type 2 diabetes

Final patient enrolled in phase IIa trial of T3D Therapeutics' T3D-959

ChemoCentryx reports topline results from CLASSIC study of CCX-168

Tri-I TDI expands relationship with Takeda into antibody drug discovery

Cantabio Pharmaceuticals enters agreement to evaluate chaperone drug candidates for PD

Nemus Bioscience's THC prodrug superior in animal models of IOP

Clinical data for GS-5745 in rheumatoid arthritis patients

Phase III trial of omadacycline in ABSSSI meets primary and secondary endpoints

Celgene joins DNDi's Neglected Tropical Diseases Drug Discovery Booster consortium

Kissei Pharmaceutical launches Glufast orally disintegrating tablets in Japan

FcgammaRIIb may predict time to treatment in CLL

Kiyatec collaborates with Mayo Clinic in ovarian cancer

Miraca Life Sciences launches InformTx therapeutic drug monitoring for IBD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...